Evidence map›Paper›PMID 29222118›Full record

ArticleRNA (New York, N.Y.)2018

Purine- and pyrimidine-triple-helix-forming oligonucleotides recognize qualitatively different target sites at the ribosomal DNA locus.

Rodrigo Maldonado, Michael Filarsky, Ingrid Grummt, Gernot Längst

Open access · bronzeAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Non-canonical DNA structures in the human ribosomal DNA.Histochemistry and cell biology · 2023
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Rodrigo MaldonadoBiochemistry Centre Regensburg (BCR), Universität Regensburg, 93053 Regensburg, Germany.
Michael FilarskyBiochemistry Centre Regensburg (BCR), Universität Regensburg, 93053 Regensburg, Germany.
Ingrid GrummtDivision of Molecular Biology of the Cell II, German Cancer Research Center (DKFZ), DKFZ-ZMBH Alliance, 69120 Heidelberg, Germany.
Gernot LängstBiochemistry Centre Regensburg (BCR), Universität Regensburg, 93053 Regensburg, Germany.ORCID 0000-0002-8232-1179
University of Regensburg · DEGerman Cancer Research Center · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Triplexes are noncanonical DNA structures, which are functionally associated with regulation of gene expression through ncRNA targeting to chromatin. Based on the rules of Hoogsteen base-pairing, polypurine sequences of a duplex can potentially form triplex structures with single-stranded oligonucleotides. Prediction of triplex-forming sequences by bioinformatics analyses have revealed enrichment of potential triplex targeting sites (TTS) at regulatory elements, mainly in promoters and enhancers, suggesting a potential function of RNA-DNA triplexes in transcriptional regulation. Here, we have quantitatively evaluated the potential of different sequences of human and mouse ribosomal RNA genes (

Indexed as

AnimalsBase PairingBinding SitesDNADNA, RibosomalElectrophoretic Mobility Shift AssayHumansMiceOligonucleotidesPoint MutationPromoter Regions, GeneticPurinesPyrimidinesRegulatory Sequences, Nucleic AcidDNADNA, RibosomalOligonucleotidespurinePurinespyrimidinePyrimidinestriplex DNAmicroscale thermophoresisribosomal DNAtriplexestriplex-forming oligos

Identifiers

PMID29222118
PMCPMC5824356
OpenAlexW2772111037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.